VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $2.62 Million Investment in HealthEquity, Inc. $HQY

Posted by George Bondi on Sep 11th, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 29,000 shares of the company’s stock, valued at approximately $2,619,000.

Other large investors also recently modified their holdings of the company. California State Teachers Retirement System lifted its holdings in shares of HealthEquity by 8,679.7% during the 2nd quarter. California State Teachers Retirement System now owns 8,832,754 shares of the company’s stock valued at $797,774,000 after purchasing an additional 8,732,150 shares in the last quarter. HB Wealth Management LLC increased its stake in HealthEquity by 70.2% during the 2nd quarter. HB Wealth Management LLC now owns 4,671 shares of the company’s stock worth $422,000 after purchasing an additional 1,927 shares in the last quarter. Three Seasons Wealth LLC increased its stake in HealthEquity by 41.9% during the 2nd quarter. Three Seasons Wealth LLC now owns 16,980 shares of the company’s stock worth $1,534,000 after purchasing an additional 5,014 shares in the last quarter. Concurrent Investment Advisors LLC raised its holdings in HealthEquity by 44.3% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 11,318 shares of the company’s stock worth $1,022,000 after buying an additional 3,472 shares during the period. Finally, Nykredit A S acquired a new stake in HealthEquity during the 2nd quarter worth approximately $290,000. 99.55% of the stock is currently owned by institutional investors.

Insider Activity

In other HealthEquity news, EVP Michael Fiore sold 2,354 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the transaction, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,456 shares of company stock worth $1,256,664 in the last quarter. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Stock Up 2.0%

Shares of HQY stock opened at $94.55 on Friday. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62. The firm’s fifty day moving average price is $99.58 and its two-hundred day moving average price is $89.18. The firm has a market capitalization of $7.82 billion, a P/E ratio of 34.13, a PEG ratio of 1.46 and a beta of 0.22.

HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. The company had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. HealthEquity’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Barrington Research restated an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, September 2nd. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research report on Friday, August 28th. Finally, Citizens Jmp upped their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $111.87.

View Our Latest Research Report on HealthEquity

HealthEquity Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.